Karessa Pharma in final negotiations with manufacturing company regarding start of manufacturing of the drug candidate Vigressa™
Karessa Pharma announces today that the company has entered into final negotiations with Laboratories Plasto Santé (PlastoPharma) regarding the manufacturing of pharmaceuticals for the upcoming clinical trial of Vigressa™ - a drug candidate with the potential to improve the treatment of impotence. The ambition for the cooperation with PlastoPharma is also to ensure a well-functioning and cost-effective manufacturing of Vigressa™ on a commercial scale for future market launch.PlastoPharma is a privately owned contract manufacturer with more than 20 years of experience in transdermal, film-